SOPHIA GENETICS SA (SOPH) Institutional Ownership Changes & 13F Activity
SOPHIA GENETICS SA (SOPH). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Ameriprise Financial Inc, Awm Investment Company, Inc., Royce & Associates Lp, Silvercrest Asset Management Group Llc, and Archon Capital Management Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Citadel Advisors Llc | Buy | +38,497 | — | 38,497 | $222.13K | Q2 2026 | Sep 02, 2026 |
| Ameriprise Financial Inc | Buy | +2,216,752 | — | 2,216,752 | $12.79M | Q2 2026 | Aug 14, 2026 |
| Awm Investment Company, Inc. | Buy | +1,700,000 | — | 1,700,000 | $9.81M | Q2 2026 | Aug 14, 2026 |
| Royce & Associates Lp | Buy | +1,565,424 | +86.2% | 3,381,736 | $19.51M | Q2 2026 | Aug 14, 2026 |
| Silvercrest Asset Management Group Llc | Buy | +1,428,470 | — | 1,428,470 | $8.24M | Q2 2026 | Aug 14, 2026 |
| Archon Capital Management Llc | Buy | +250,000 | +56.6% | 691,413 | $3.99M | Q2 2026 | Aug 14, 2026 |
| Sei Investments Co | Sell | -192,843 | -53.9% | 165,045 | $952.30K | Q2 2026 | Aug 14, 2026 |
| Maven Securities Ltd | Buy | +150,000 | — | 150,000 | $865.50K | Q2 2026 | Aug 14, 2026 |
| Millennium Management Llc | Buy | +128,267 | +1264.7% | 138,409 | $798.62K | Q2 2026 | Aug 14, 2026 |
| Jane Street Group, Llc | Buy | +108,062 | — | 108,062 | $623.52K | Q2 2026 | Aug 14, 2026 |
| Xtx Topco Ltd | Buy | +57,140 | — | 57,140 | $329.70K | Q2 2026 | Aug 14, 2026 |
| Longaeva Partners L.P. | Buy | +50,000 | — | 50,000 | $288.50K | Q2 2026 | Aug 14, 2026 |
| Two Sigma Investments, Lp | Buy | +48,135 | +472.0% | 58,333 | $336.58K | Q2 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Sell | -28,030 | -48.6% | 29,598 | $170.78K | Q2 2026 | Aug 14, 2026 |
| Hrt Financial Lp | Buy | +22,532 | — | 22,532 | $130.00K | Q2 2026 | Aug 14, 2026 |
| Bank Of America Corp | Buy | +22,300 | — | 22,300 | $128.67K | Q2 2026 | Aug 14, 2026 |
| Heights Capital Management, Inc | Buy | +20,000 | — | 20,000 | $115.40K | Q2 2026 | Aug 14, 2026 |
| Royal Bank Of Canada | Sell | -18,662 | -96.3% | 719 | $4.00K | Q2 2026 | Aug 14, 2026 |
| Prelude Capital Management, Llc | Buy | +15,596 | — | 15,596 | $89.99K | Q2 2026 | Aug 14, 2026 |
| Kennedy Capital Management Llc | Sell | -9,823 | -1.1% | 917,977 | $5.30M | Q2 2026 | Aug 14, 2026 |
| Barclays Plc | Buy | +2,677 | — | 2,677 | $15.45K | Q2 2026 | Aug 14, 2026 |
| Ensign Peak Advisors, Inc | Sell | -300 | -0.1% | 444,654 | $2.57M | Q2 2026 | Aug 14, 2026 |
| Renaissance Technologies LLC | Buy | +53,500 | +89.5% | 113,300 | $653.74K | Q2 2026 | Aug 13, 2026 |
| Acadian Asset Management Llc | Buy | +22,600 | — | 22,600 | $129.00K | Q2 2026 | Aug 13, 2026 |
| Morgan Stanley | Buy | +14,317 | +61.8% | 37,497 | $216.36K | Q2 2026 | Aug 13, 2026 |
| Ubs Group Ag | Sell | -10,782 | -11.7% | 81,444 | $469.93K | Q2 2026 | Aug 13, 2026 |
| Centiva Capital, Lp | Buy | +6,320 | +50.4% | 18,869 | $108.87K | Q2 2026 | Aug 13, 2026 |
| Federated Hermes, Inc. | Sell | -48,018 | -25.3% | 141,992 | $819.29K | Q2 2026 | Aug 12, 2026 |
| Stonex Group Inc. | Buy | +45,523 | — | 45,523 | $229.89K | Q2 2026 | Aug 12, 2026 |
| Westfield Capital Management Co Lp | Buy | +32,907 | — | 32,907 | $189.87K | Q2 2026 | Aug 12, 2026 |
Frequently asked questions about SOPH activity
Which institutional owners are buying SOPH?
Institutional owners buying SOPH include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in SOPH activity?
"Buy" means an investor increased their reported position in SOPH compared to the prior reporting period. This reflects growing exposure to SOPHIA GENETICS SA (SOPH) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in SOPH increasing?
Institutional interest in SOPH can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related SOPH Institutional Insights
- SOPH Overview
- SOPH 13F Institutional Holders
- SOPH Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- SOPH Insider Trading & SEC Form 4 Activity
- SOPH Articles
- Top Institutional Investor Stock Rankings